horse anti-SARS-CoV immunoglobulin (National Vaccine and Serum Institute)

N/A

Report date: 2026/01/26 17:59:11

Base Information

Drug Namehorse anti-SARS-CoV immunoglobulin (National Vaccine and Serum Institute)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunoglobulin modulatorsSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinaseImmunoglobulin
Therapy Area/IndicationsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesNational Vaccine and Serum Institute, China
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Vaccine and Serum Institute, China
Active IndicationsN/A
Inactive IndicationsSevere Acute Respiratory Syndrome

Other Information

ATC CodeN/A
Related LinksN/A